Lifeward Ltd. — Director's Dealing 2016

Jun 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ReWalk Robotics Ltd. (RWLK)
CIK: 0001607962
Period of Report: 2016-06-02

Reporting Person: SCP Vitalife Partners (Israel) II, L.P. (10% Owner)
Reporting Person: SCP Vitalife II Associates, L.P. (10% Owner)
Reporting Person: SCP Vitalife II GP, Ltd. (10% Owner)
Reporting Person: CHURCHILL WINSTON J (10% Owner)
Reporting Person: LUDOMIRSKI ABRAHAM (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-02	Ordinary Shares, par value NIS 0.01 per share	S	3448	$7.8911	Disposed	388044	Direct
2016-06-03	Ordinary Shares, par value NIS 0.01 per share	S	1324	$7.8961	Disposed	386720	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.8500 to $8.0000, inclusive. The reporting person undertakes to provide to ReWalk Robotics, Ltd. ("ReWalk"), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

F2: The Ordinary Shares are directly held by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.8600 to $7.9500, inclusive. The reporting person undertakes to provide to ReWalk, any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.